1 – 15 of 309
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Care of Late-Stage Parkinsonism : Resource Utilization of the Disease in Five European Countries
(
- Contribution to journal › Article
-
Mark
Facing and dealing with emotional turbulence : Living with newly diagnosed Parkinson's disease
2024) In Scandinavian Journal of Caring Sciences(
- Contribution to journal › Article
-
Mark
Inflammatory bowel disease induces pathological α-synuclein aggregation in the human gut and brain
(
- Contribution to journal › Article
-
Mark
Forced LMX1A expression induces dorsal neural fates and disrupts patterning of human embryonic stem cells into ventral midbrain dopaminergic neurons
(
- Contribution to journal › Article
-
Mark
Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa Infusion
2024) In Movement Disorders Clinical Practice(
- Contribution to journal › Article
-
Mark
Immune Mechanisms in Parkinson's Disease and Epilepsy. Preclinical Findings and Clinical Perspectives.
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2023
-
Mark
Ganglioside GM3 stimulates lipid-protein co-assembly in α-synuclein amyloid formation
(
- Contribution to journal › Article
-
Mark
α-Synuclein induces deficiency in clathrin-mediated endocytosis through inhibiting synaptojanin1 expression
(
- Contribution to journal › Article
-
Mark
Dopamine agonist serum concentrations and impulse control disorders in Parkinson's disease
2023) In European Journal of Neurology(
- Contribution to journal › Article
-
Mark
A Paradigm Shift in the Management of Patients with Parkinson's Disease
(
- Contribution to journal › Scientific review
-
Mark
Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in rats
(
- Contribution to journal › Article
-
Mark
Neurofilament light predicts worse nonmotor symptoms and depression in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Healthcare resource utilization and device-aided therapy discussions with eligible patients across the Parkinson's disease continuum : Revelations from the MANAGE-PD validation cohort
(
- Contribution to journal › Article
-
Mark
Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
The etiology of Parkinson's disease. Genetic and non-genetic risk factors for a multifactorial disease
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)